Entrada Therapeutics, Inc. (TRDA)

Entrada Therapeutics Revenue

Entrada Therapeutics had revenue of $19.57M in the quarter ending September 30, 2024, a decrease of -55.25%. This brings the company's revenue in the last twelve months to $215.23M, up 146.92% year-over-year. In the year 2023, Entrada Therapeutics had annual revenue of $129.01M.

• Revenue (ttm): $215.23M
• Revenue Growth: +146.92%
• P/S Ratio: 2.90
• Revenue / Employee: $1,353,660
• Employees: 159
• Market Cap: 622.78M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	129.01M	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.